Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03112603
Brief Title: A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

First Submitted : April 4, 2017
First Submitted that Met QC Criteria : April 7, 2017
First Posted : April 13, 2017

Certification/Extension First Submitted : May 4, 2021
Certification/Extension First Submitted that Met QC Criteria : May 4, 2021
Certification/Extension First Posted : May 7, 2021

Last Update Submitted that Met QC Criteria : May 4, 2021
Last Update Posted : May 7, 2021